Lyme Disease: Where's the Vaccine?



- Scientists are pushing for the development of a new vaccine for Lyme disease.

- A first-generation vaccine worked pretty well but was pulled from the market in 2002.

- The number of Lyme disease cases has been increasing every year.

It's tick season again, which means it's also Lyme disease season, and that puts outdoorsy people on edge.

The tick-borne illness, after all, brings fevers, aches and other nasty symptoms that, for about 10 percent of victims, last for months or more.

Doctors know a lot about Lyme and the bacteria that transmit it. Yet, there is no human vaccine for the disease -- at least not anymore. While there is a highly effective vaccine available for dogs, a series of unfortunate events doomed a first-generation human vaccine, which was pulled from the market in 2002.

As numbers of Lyme cases continue to rise each year, some scientists are pushing to bring back a Lyme vaccine, either in its old form or in a new one. Failing to offer a vaccine, they say, is failing the many millions of people who live in the vicinity of deer ticks.

"In my opinion, this is a public health fiasco," said Stanley A. Plotkin, a pediatrician and infectious disease specialist at the University of Pennsylvania, Philadelphia. "There are well over 20,000 annual cases of Lyme disease and probably more than that. When else do you have a disease with that incidence where you know you can prevent it with a vaccine, but you don't make it?"

NEWS: 'Heartland' Virus Discovered in Sick Missouri Farmers

Cases of diagnosed Lyme Disease have steadily risen in the United States, according to data collected by the Centers for Disease Control and Prevention, from just over 10,000 confirmed illnesses in 1995 to at least 30,000 in 2009. Better surveillance explains some of that trend, said Paul Mead, a medical epidemiologist at the CDC in Ft. Collins, Colo. But numbers are certainly not going down.

In 2009, 95 percent of Lyme's cases occurred in just 12 states, mostly in the Northeast and Upper Midwest. Even so, Lyme was the sixth most common infectious disease in the country that year, below chlamydia and gonorrhea, but comparable in number to AIDS, and above hepatitis and tuberculosis.

Despite recommendations to use repellents and to do daily tick checks with a partner, however, case reports continue to climb.

"The prevention of Lyme disease is a very frustrating undertaking in the world of communicable diseases," Mead said. "I think we're open to anything that would be helpful in terms of trying to control the disease."

There used to be more options. In 1998, the pharmaceutical company SmithKline Beecham (now GlaxoSmithKline) released a Lyme vaccine that showed promise.

Recommended for you